Z

ZimVie Inc
NASDAQ:ZIMV

Watchlist Manager
ZimVie Inc
NASDAQ:ZIMV
Watchlist
Price: 11.51 USD 2.77% Market Closed
Market Cap: 318.6m USD

ZimVie Inc
Investor Relations

Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. The company is headquartered in Westminster, Colorado and currently employs 2,700 full-time employees. The company went IPO on 2022-02-14. The firm develops, manufactures, and markets a portfolio of products and solutions designed to treat a range of spine pathologies and support dental tooth replacement and restoration procedures. The Company’s operations are managed on a products basis and include two operating segments: the spine products segment, and the dental products segment. Its spine products segment focused on designing, manufacturing, and distributing medical devices and surgical instruments to deliver solutions for individuals with back or neck pain caused by degenerative conditions, deformities, tumors, or traumatic injury of the spine. Its product portfolio includes Mobi-C Cervical Disc and the Tether device. Its dental products segment is focused on designing, manufacturing and/or distributing of dental implant solutions. Its products include T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, and BellaTek Encode Impression System.

Show more
Loading

Earnings Calls

2023 Q4
Feb 2, 2024
Show Transcript
Previous
Next
Stabilizing Interest, Quality, and Expenses
2023 Q4
Feb 2, 2024

The company experienced a $200,000 decline in Q4 interest income due to a decrease in interest-earning assets and lower loan origination activities. Net interest margin is expected to remain stable in the first half and improve in the second half of 2024 as higher-yielding investments mature. Credit quality remains stable, supporting the portfolio's strength, particularly in multifamily and lower-risk commercial real estate. Expense guidance for the next year is projected between $41 million and $42.5 million, with potential savings from a branch sale and reduced legal costs. The company aims to maintain a steady dividend return and targets a 5-8% loan growth, leading to a projected loan-to-deposit ratio of about 90%. As for return on equity, double-digit figures are considered achievable in the future. Efforts to boost fee income are underway, particularly in retail banking and the Trust Department, with an efficiency ratio goal between the low to mid-60s percentage range.

Show Full Analysis

Management

Mr. Vafa Jamali
President, CEO & Director
No Bio Available
Mr. Richard J. Heppenstall
Executive VP, CFO & Treasurer
No Bio Available
Ms. Heather Kidwell
Senior VP, Chief Legal, HR & Compliance Officer and Corporate Secretary
No Bio Available
Mr. Indraneel Kanaglekar
Senior VP & Chief Commercial Officer
No Bio Available
Sandra Schneider
Chief Accounting Officer
No Bio Available
Mr. Steve Rondeau
Senior VP & Chief Information Officer
No Bio Available
Ms. Ann Vu
SVP & Chief Quality and Regulatory Affairs Officer
No Bio Available

Contacts

Address
COLORADO
Westminster
10225 Westmoor Drive
Contacts
+13034437500.0